SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for AGENUS INC (AGEN) (CIK 0001098972) (AGEN) — Nov 18, 2019

AGENUS INC (AGEN) (CIK 0001098972)
Date: Nov. 18, 2019 · CIK: 0001098972 · Accession: 0000000000-19-015607

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 000-29089

Date
November 18, 2019
Author
Garo H. Armen, Ph.D.
Form
UPLOAD
Company
AGENUS INC (AGEN) (CIK 0001098972)

Letter

November 18, 2019 Garo H. Armen, Ph.D. Chief Executive Officer Agenus Inc. 3 Forbes Road Lexington, Massachusetts 02421 Re:Agenus Inc. Form 10-K for Fiscal Year Ended December 31, 2018 Filed March 18, 2019 File No. 000-29089 Dear Dr. Armen: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Zachary R. Blume - Ropes & Gray LLP

Show Raw Text
November 18, 2019
Garo H. Armen, Ph.D.
Chief Executive Officer
Agenus Inc.
3 Forbes Road
Lexington, Massachusetts 02421
Re:Agenus Inc.
Form 10-K for Fiscal Year Ended December 31, 2018
Filed March 18, 2019
File No. 000-29089
Dear Dr. Armen:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Zachary R. Blume - Ropes & Gray LLP